{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:24:59Z","timestamp":1787599499817,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA283364"],"award-info":[{"award-number":["R01 CA283364"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA254838-01"],"award-info":[{"award-number":["P50 CA254838-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA258904"],"award-info":[{"award-number":["R01 CA258904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R35CA304457"],"award-info":[{"award-number":["1R35CA304457"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-2236662"],"award-info":[{"award-number":["DGE-2236662"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"DOI":"10.1038\/s41375-026-03098-8","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:59:10Z","timestamp":1787554750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia"],"prefix":"10.1038","author":[{"given":"Zhendong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-2202","authenticated-orcid":false,"given":"Kurtis N.","family":"McCannell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista A.","family":"Budinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-8228","authenticated-orcid":false,"given":"Yuqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tittley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy Fange","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-6316","authenticated-orcid":false,"given":"Junwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6171","authenticated-orcid":false,"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"3098_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"3098_CR2","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"3098_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"3098_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"3098_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/bjh.17746","volume":"196","author":"S Kayser","year":"2022","unstructured":"Kayser S, Levis MJ. Updates on targeted therapies for acute myeloid leukaemia. Br J Haematol. 2022;196:316\u201328.","journal-title":"Br J Haematol"},{"key":"3098_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccell.2017.12.002","volume":"33","author":"Y Xu","year":"2018","unstructured":"Xu Y, Milazzo JP, Somerville TDD, Tarumoto Y, Huang Y-H, Ostrander EL, et al. A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia. Cancer Cell. 2018;33:13\u201328.e8.","journal-title":"Cancer Cell"},{"key":"3098_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trecan.2015.07.001","volume":"1","author":"AS Bhagwat","year":"2015","unstructured":"Bhagwat AS, Vakoc CR. Targeting transcription factors in cancer. Trends Cancer. 2015;1:53\u201365.","journal-title":"Trends Cancer"},{"key":"3098_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner JE, Hnisz D, Young RA. Transcriptional addiction in cancer. Cell. 2017;168:629\u201343.","journal-title":"Cell"},{"key":"3098_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564\u2013.e16.","journal-title":"Cell"},{"key":"3098_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478:524\u20138.","journal-title":"Nature"},{"key":"3098_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","volume":"22","author":"A Katti","year":"2022","unstructured":"Katti A, Diaz BJ, Caragine CM, Sanjana NE, Dow LE. CRISPR in cancer biology and therapy. Nat Rev Cancer. 2022;22:259\u201379.","journal-title":"Nat Rev Cancer"},{"key":"3098_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, et al. Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet. 2017;49:1779\u201384.","journal-title":"Nat Genet"},{"key":"3098_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.molcel.2026.02.003","volume":"86","author":"Z Cao","year":"2026","unstructured":"Cao Z, Yu S, Peng J, Barrett DR, Liu Y, Sussman JH, et al. CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples. Mol Cell. 2026;86:968\u201385.e7.","journal-title":"Mol Cell"},{"key":"3098_CR14","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1158\/2159-8290.CD-25-0299","volume":"15","author":"P Zhang","year":"2025","unstructured":"Zhang P, Cao Z, Pan X, Liu Y, Castro C, Kim WJ, et al. Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignancies. Cancer Discov. 2025;15:2530\u201353.","journal-title":"Cancer Discov"},{"key":"3098_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41594-019-0312-0","volume":"26","author":"K Tzelepis","year":"2019","unstructured":"Tzelepis K, Rausch O, Kouzarides T. RNA-modifying enzymes and their function in a chromatin context. Nat Struct Mol Biol. 2019;26:858\u201362.","journal-title":"Nat Struct Mol Biol"},{"key":"3098_CR16","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1016\/j.cell.2025.06.021","volume":"188","author":"MW Hentze","year":"2025","unstructured":"Hentze MW, Sommerkamp P, Ravi V, Gebauer F. Rethinking RNA-binding proteins: Riboregulation challenges prevailing views. Cell. 2025;188:4811\u201327.","journal-title":"Cell"},{"key":"3098_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm2178","volume":"8","author":"BM Lunde","year":"2007","unstructured":"Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 2007;8:479\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3098_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC-W Lee","year":"2016","unstructured":"Lee SC-W, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016;22:976\u201386.","journal-title":"Nat Med"},{"key":"3098_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-pharmtox-062124-035809","volume":"66","author":"AM Lewis","year":"2026","unstructured":"Lewis AM, Weis K, Abdel-Wahab O. RNA splicing as a therapeutic target in cancer. Annu Rev Pharmacol Toxicol. 2026;66:441\u201363.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3098_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Mill\u00e1n-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552:126\u201331.","journal-title":"Nature"},{"key":"3098_CR21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"3098_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ccell.2018.01.012","volume":"33","author":"T Yamauchi","year":"2018","unstructured":"Yamauchi T, Masuda T, Canver MC, Seiler M, Semba Y, Shboul M, et al. Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS. Cancer Cell. 2018;33:386\u2013400.e5.","journal-title":"Cancer Cell"},{"key":"3098_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369\u201321.e7.","journal-title":"Cancer Cell"},{"key":"3098_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ccell.2022.12.002","volume":"41","author":"E Wang","year":"2023","unstructured":"Wang E, Pineda JMB, Kim WJ, Chen S, Bourcier J, Stahl M, et al. Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Cancer Cell. 2023;41:164\u201380.e8.","journal-title":"Cancer Cell"},{"key":"3098_CR25","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI80046","volume":"126","author":"JK Palanichamy","year":"2016","unstructured":"Palanichamy JK, Tran TM, Howard JM, Contreras JR, Fernando TR, Sterne-Weiler T, et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Invest. 2016;126:1495\u2013511.","journal-title":"J Clin Invest"},{"key":"3098_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03149-8","volume":"25","author":"M Zhang","year":"2024","unstructured":"Zhang M, Hyle J, Chen X, Xin Y, Jin Y, Zhang J, et al. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome Biol. 2024;25:16.","journal-title":"Genome Biol"},{"key":"3098_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"3098_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell. 2018;22:191\u2013205.e9.","journal-title":"Cell Stem Cell"},{"key":"3098_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-neuro-083022-113120","volume":"46","author":"X-D Fu","year":"2023","unstructured":"Fu X-D, Mobley WC. Therapeutic potential of PTB inhibition through converting glial cells to neurons in the brain. Annu Rev Neurosci. 2023;46:145\u201365.","journal-title":"Annu Rev Neurosci"},{"key":"3098_CR30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.molcel.2009.12.003","volume":"36","author":"Y Xue","year":"2009","unstructured":"Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon Y-S, et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell. 2009;36:996\u20131006.","journal-title":"Mol Cell"},{"key":"3098_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s41048-018-0066-y","volume":"4","author":"J Hu","year":"2018","unstructured":"Hu J, Qian H, Xue Y, Fu X-D. PTB\/nPTB: master regulators of neuronal fate in mammals. Biophys Rep. 2018;4:204\u201314.","journal-title":"Biophys Rep"},{"key":"3098_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2019.06.001","volume":"178","author":"R Xiao","year":"2019","unstructured":"Xiao R, Chen J-Y, Liang Z, Luo D, Chen G, Lu ZJ, et al. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 2019;178:107\u2013121e18.","journal-title":"Cell"},{"key":"3098_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/10815589241264783","volume":"72","author":"L Xing","year":"2024","unstructured":"Xing L, Guo X, Zhang X, Wang Y, He F, Ren J. PTBP1 is a potential indicator of disease progression in acute myeloid leukemia. J Investig Med. 2024;72:891\u20139.","journal-title":"J Investig Med"},{"key":"3098_CR34","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.4149\/neo_2022_220314N279","volume":"69","author":"Q-X Zhang","year":"2022","unstructured":"Zhang Q-X, Pan Y-M, Xiao H-L, An N, Deng S-S, Du X. Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy. Neoplasma. 2022;69:1198\u2013208.","journal-title":"Neoplasma"},{"key":"3098_CR35","first-page":"654547","volume":"2025","author":"A Dhir","year":"2025","unstructured":"Dhir A, Ethell A, Watkins R, Lam C, Tur-Rodriguez K, Persinger J, et al. The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival. bioRxiv. 2025;2025:654547 05.16.","journal-title":"bioRxiv"},{"key":"3098_CR36","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/bloodadvances.2020001710","volume":"4","author":"M-P Garcia-Cuellar","year":"2020","unstructured":"Garcia-Cuellar M-P, Lawlor J, B\u00f6ttcher M, Mougiakakos D, Metzler M, Slany RK. Exploitable metabolic dependencies in MLL-ENL-induced leukemia. Blood Adv. 2020;4:3626\u201338.","journal-title":"Blood Adv"},{"key":"3098_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104778","volume":"299","author":"C Carico","year":"2023","unstructured":"Carico C, Cui J, Acton A, Placzek WJ. Polypyrimidine tract binding protein 1 (PTBP1) contains a novel regulatory sequence, the rBH3, that binds the prosurvival protein MCL1. J Biol Chem. 2023;299:104778.","journal-title":"J Biol Chem"},{"key":"3098_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB, Vakoc CR. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol. 2015;33:661\u20137.","journal-title":"Nat Biotechnol"},{"key":"3098_CR39","doi-asserted-by":"publisher","first-page":"D301","DOI":"10.1093\/nar\/gkq1069","volume":"39","author":"KB Cook","year":"2011","unstructured":"Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 2011;39:D301\u2013308.","journal-title":"Nucleic Acids Res"},{"key":"3098_CR40","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1016\/j.molcel.2021.07.018","volume":"81","author":"Z Cao","year":"2021","unstructured":"Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, et al. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Mol Cell. 2021;81:3604\u201322.e10.","journal-title":"Mol Cell"},{"key":"3098_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"3098_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature15548","volume":"527","author":"Z Dou","year":"2015","unstructured":"Dou Z, Xu C, Donahue G, Shimi T, Pan J-A, Zhu J, et al. Autophagy mediates degradation of nuclear lamina. Nature. 2015;527:105\u20139.","journal-title":"Nature"},{"key":"3098_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nmeth.1541","volume":"8","author":"H Choi","year":"2011","unstructured":"Choi H, Larsen B, Lin Z-Y, Breitkreutz A, Mellacheruvu D, Fermin D, et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods. 2011;8:70\u201373.","journal-title":"Nat Methods"},{"key":"3098_CR44","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","volume":"28","author":"B Snel","year":"2000","unstructured":"Snel B, Lehmann G, Bork P, Huynen MA. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 2000;28:3442\u20134.","journal-title":"Nucleic Acids Res"},{"key":"3098_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"3098_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3098_CR47","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199\u2013W205.","journal-title":"Nucleic Acids Res"},{"key":"3098_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"3098_CR49","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41596-023-00944-2","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xie Z, Kutschera E, Adams JI, Kadash-Edmondson KE, Xing Y. rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data. Nat Protoc. 2024;19:1083\u2013104.","journal-title":"Nat Protoc"},{"key":"3098_CR50","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11752","volume":"5","author":"J Vaquero-Garcia","year":"2016","unstructured":"Vaquero-Garcia J, Barrera A, Gazzara MR, Gonz\u00e1lez-Vallinas J, Lahens NF, Hogenesch JB, et al. A new view of transcriptome complexity and regulation through the lens of local splicing variations. Elife. 2016;5:e11752.","journal-title":"Elife"},{"key":"3098_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-7204-3_14","volume":"1648","author":"EL Van Nostrand","year":"2017","unstructured":"Van Nostrand EL, Nguyen TB, Gelboin-Burkhart C, Wang R, Blue SM, Pratt GA, et al. Robust, cost-effective profiling of RNA binding protein targets with single-end enhanced crosslinking and immunoprecipitation (seCLIP). Methods Mol Biol. 2017;1648:177\u2013200.","journal-title":"Methods Mol Biol"},{"key":"3098_CR52","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cell.2016.09.038","volume":"167","author":"F Liu","year":"2016","unstructured":"Liu F, Clark W, Luo G, Wang X, Fu Y, Wei J, et al. ALKBH1-Mediated tRNA demethylation Regulates Translation. Cell. 2016;167:816\u201328.e16.","journal-title":"Cell"},{"key":"3098_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"ENCODE Project Consortium","year":"2012","unstructured":"ENCODE Project ConsortiumAn integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374.","journal-title":"Nature"},{"key":"3098_CR54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41594-020-0477-6","volume":"27","author":"E-C Luo","year":"2020","unstructured":"Luo E-C, Nathanson JL, Tan FE, Schwartz JL, Schmok JC, Shankar A, et al. Large-scale tethered function assays identify factors that regulate mRNA stability and translation. Nat Struct Mol Biol. 2020;27:989\u20131000.","journal-title":"Nat Struct Mol Biol"},{"key":"3098_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10\u201312.","journal-title":"EMBnet J"},{"key":"3098_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-015-0041-9","volume":"6","author":"W Bao","year":"2015","unstructured":"Bao W, Kojima KK, Kohany O. Repbase Update, a database of repetitive elements in eukaryotic genomes. Mob DNA. 2015;6:11.","journal-title":"Mob DNA"},{"key":"3098_CR57","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389.","journal-title":"Mol Cell"},{"key":"3098_CR58","doi-asserted-by":"publisher","first-page":"D243","DOI":"10.1093\/nar\/gkae1038","volume":"53","author":"T Goldfarb","year":"2025","unstructured":"Goldfarb T, Kodali VK, Pujar S, Brover V, Robbertse B, Farrell CM, et al. NCBI RefSeq: reference sequence standards through 25 years of curation and annotation. Nucleic Acids Res. 2025;53:D243\u2013D257.","journal-title":"Nucleic Acids Res"},{"key":"3098_CR59","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng.3854","volume":"49","author":"LP Vu","year":"2017","unstructured":"Vu LP, Prieto C, Amin EM, Chhangawala S, Krivtsov A, Calvo-Vidal MN, et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017;49:866\u201375.","journal-title":"Nat Genet"},{"key":"3098_CR60","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2012-07-442004","volume":"121","author":"Z Li","year":"2013","unstructured":"Li Z, Zhang Z, Li Y, Arnovitz S, Chen P, Huang H, et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood. 2013;121:1422\u201331.","journal-title":"Blood"},{"key":"3098_CR61","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL\u2013AF9. Nature. 2006;442:818\u201322.","journal-title":"Nature"},{"key":"3098_CR62","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrc2253","volume":"7","author":"AV Krivtsov","year":"2007","unstructured":"Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7:823\u201333.","journal-title":"Nat Rev Cancer"},{"key":"3098_CR63","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.molcel.2018.02.011","volume":"69","author":"Y Tarumoto","year":"2018","unstructured":"Tarumoto Y, Lu B, Somerville TDD, Huang Y-H, Milazzo JP, Wu XS, et al. LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia. Mol Cell. 2018;69:1017\u201327.e6.","journal-title":"Mol Cell"},{"key":"3098_CR64","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ccell.2018.10.015","volume":"34","author":"B Lu","year":"2018","unstructured":"Lu B, Klingbeil O, Tarumoto Y, Somerville TDD, Huang Y-H, Wei Y, et al. A transcription factor addiction in leukemia imposed by the MLL promoter sequence. Cancer Cell. 2018;34:970\u201381.e8.","journal-title":"Cancer Cell"},{"key":"3098_CR65","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1101\/gad.17269211","volume":"25","author":"J Zuber","year":"2011","unstructured":"Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev. 2011;25:1628\u201340.","journal-title":"Genes Dev"},{"key":"3098_CR66","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1093\/nar\/gku519","volume":"42","author":"I Mickleburgh","year":"2014","unstructured":"Mickleburgh I, Kafasla P, Cherny D, Llorian M, Curry S, Jackson RJ, et al. The organization of RNA contacts by PTB for regulation of FAS splicing. Nucleic Acids Res. 2014;42:8605\u201320.","journal-title":"Nucleic Acids Res"},{"key":"3098_CR67","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1126\/science.1114066","volume":"309","author":"FC Oberstrass","year":"2005","unstructured":"Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, et al. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science. 2005;309:2054\u20137.","journal-title":"Science"},{"key":"3098_CR68","doi-asserted-by":"publisher","first-page":"11218","DOI":"10.3390\/ijms241311218","volume":"24","author":"C Carico","year":"2023","unstructured":"Carico C, Placzek WJ. Reviewing PTBP1 domain modularity in the pre-genomic era: a foundation to guide the next generation of exploring PTBP1 structure\u2013function relationships. Int J Mol Sci. 2023;24:11218.","journal-title":"Int J Mol Sci"},{"key":"3098_CR69","doi-asserted-by":"publisher","first-page":"e1003442","DOI":"10.1371\/journal.pcbi.1003442","volume":"10","author":"A Han","year":"2014","unstructured":"Han A, Stoilov P, Linares AJ, Zhou Y, Fu X-D, Black DL. De Novo prediction of PTBP1 binding and splicing targets reveals unexpected features of its RNA recognition and function. PLoS Comput Biol. 2014;10:e1003442.","journal-title":"PLoS Comput Biol"},{"key":"3098_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110793","volume":"39","author":"M Rehn","year":"2022","unstructured":"Rehn M, Wenzel A, Frank A-K, Schuster MB, Pundhir S, J\u00f8rgensen N, et al. PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents. Cell Rep. 2022;39:110793.","journal-title":"Cell Rep"},{"key":"3098_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.854973","volume":"12","author":"KJ Kurtz","year":"2022","unstructured":"Kurtz KJ, Conneely SE, O\u2019Keefe M, Wohlan K, Rau RE. Murine Models of Acute Myeloid Leukemia. Front Oncol. 2022;12:854973.","journal-title":"Front Oncol"},{"key":"3098_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nbt.1720","volume":"29","author":"J Zuber","year":"2011","unstructured":"Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol. 2011;29:79\u201383.","journal-title":"Nat Biotechnol"},{"key":"3098_CR73","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1101\/gad.232710.113","volume":"27","author":"J Shi","year":"2013","unstructured":"Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe J-S, et al. Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 2013;27:2648\u201362.","journal-title":"Genes Dev"},{"key":"3098_CR74","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","volume":"113","author":"J Faber","year":"2009","unstructured":"Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M, et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood. 2009;113:2375\u201385.","journal-title":"Blood"},{"key":"3098_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105139","volume":"25","author":"BY Pingul","year":"2022","unstructured":"Pingul BY, Huang H, Chen Q, Alikarami F, Zhang Z, Qi J, et al. Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia. iScience. 2022;25:105139.","journal-title":"iScience"},{"key":"3098_CR76","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cancers13040764","volume":"13","author":"F Liss","year":"2021","unstructured":"Liss F, Frech M, Wang Y, Giel G, Fischer S, Simon C, et al. IRF8 Is an AML-specific susceptibility factor that regulates signaling pathways and proliferation of AML Cells. Cancers (Basel). 2021;13:764.","journal-title":"Cancers (Basel)"},{"key":"3098_CR77","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1101\/gad.349284.121","volume":"36","author":"T Harada","year":"2022","unstructured":"Harada T, Heshmati Y, Kalfon J, Perez MW, Xavier Ferrucio J, Ewers J, et al. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. Genes Dev. 2022;36:368\u201389.","journal-title":"Genes Dev"},{"key":"3098_CR78","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa GC, Aldoss I, DiPersio J, Cuglievan B, Stone R, Arellano M, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023;615:920\u20134.","journal-title":"Nature"},{"key":"3098_CR79","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","volume":"36","author":"AV Krivtsov","year":"2019","unstructured":"Krivtsov AV, Evans K, Gadrey JY, Eschle BK, Hatton C, Uckelmann HJ, et al. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. Cancer Cell. 2019;36:660\u201373.e11.","journal-title":"Cancer Cell"},{"key":"3098_CR80","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1200\/JCO.24.00826","volume":"43","author":"GC Issa","year":"2025","unstructured":"Issa GC, Aldoss I, Thirman MJ, DiPersio J, Arellano M, Blachly JS, et al. Menin inhibition With Revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101). J Clin Oncol. 2025;43:75\u201384.","journal-title":"J Clin Oncol"},{"key":"3098_CR81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","volume":"33","author":"N Daver","year":"2019","unstructured":"Daver N, Schlenk RF, Russell NH, Levis MJ. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019;33:299\u2013312.","journal-title":"Leukemia"},{"key":"3098_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2013.56","volume":"33","author":"K Cant\u00e9-Barrett","year":"2014","unstructured":"Cant\u00e9-Barrett K, Pieters R, Meijerink JPP. Myocyte enhancer factor 2C in hematopoiesis and leukemia. Oncogene. 2014;33:403\u201310.","journal-title":"Oncogene"},{"key":"3098_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-015-0215-4","volume":"8","author":"GS Laszlo","year":"2015","unstructured":"Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children\u2019s Oncology Group. J Hematol Oncol. 2015;8:115.","journal-title":"J Hematol Oncol"},{"key":"3098_CR84","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1182\/blood-2004-12-4840","volume":"106","author":"Y Du","year":"2005","unstructured":"Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood. 2005;106:2498\u2013505.","journal-title":"Blood"},{"key":"3098_CR85","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","volume":"27","author":"EV Makeyev","year":"2007","unstructured":"Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative Pre-mRNA splicing. Mol Cell. 2007;27:435\u201348.","journal-title":"Mol Cell"},{"key":"3098_CR86","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1101\/gad.1558107","volume":"21","author":"PL Boutz","year":"2007","unstructured":"Boutz PL, Stoilov P, Li Q, Lin C-H, Chawla G, Ostrow K, et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 2007;21:1636\u201352.","journal-title":"Genes Dev"},{"key":"3098_CR87","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand EL, Freese P, Pratt GA, Wang X, Wei X, Xiao R, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583:711\u20139.","journal-title":"Nature"},{"key":"3098_CR88","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1200\/JCO.2022.40.16_suppl.7025","volume":"40","author":"AH Chourasia","year":"2022","unstructured":"Chourasia AH, Majeski H, Pasis A, Erdman P, Oke A, Hecht D, et al. BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1\/3, for treatment of acute myeloid leukemia (AML) and solid tumors. JCO. 2022;40:7025.","journal-title":"JCO"},{"key":"3098_CR89","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2021-153575","volume":"138","author":"J Berdeja","year":"2021","unstructured":"Berdeja J, Ailawadhi S, Horwitz SM, Matous JV, Mehta-Shah N, Martin T, et al. A Phase 1 study of CFT7455, a novel degrader of IKZF1\/3, in multiple myeloma and non-Hodgkin lymphoma. Blood. 2021;138:1675.","journal-title":"Blood"},{"key":"3098_CR90","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s43018-022-00366-1","volume":"3","author":"BJ Aubrey","year":"2022","unstructured":"Aubrey BJ, Cutler JA, Bourgeois W, Donovan KA, Gu S, Hatton C, et al. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nat Cancer. 2022;3:595\u2013613.","journal-title":"Nat Cancer"},{"key":"3098_CR91","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3324\/haematol.2017.185603","volume":"103","author":"R Marke","year":"2018","unstructured":"Marke R, Leeuwen FN, van, Scheijen B. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2018;103:565\u201374.","journal-title":"Haematologica"},{"key":"3098_CR92","first-page":"4062","volume":"60","author":"K Nakase","year":"2000","unstructured":"Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, et al. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res. 2000;60:4062\u20135.","journal-title":"Cancer Res"},{"key":"3098_CR93","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood.2019001576","volume":"135","author":"Y Tarumoto","year":"2020","unstructured":"Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, et al. Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Blood. 2020;135:56\u201370.","journal-title":"Blood"},{"key":"3098_CR94","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/onc.2012.110","volume":"32","author":"J Shi","year":"2013","unstructured":"Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C, et al. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9; NrasG12D acute myeloid leukemia. Oncogene. 2013;32:930\u20138.","journal-title":"Oncogene"},{"key":"3098_CR95","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","volume":"120","author":"S Tanaka","year":"2012","unstructured":"Tanaka S, Miyagi S, Sashida G, Chiba T, Yuan J, Mochizuki-Kashio M, et al. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood. 2012;120:1107\u201317.","journal-title":"Blood"},{"key":"3098_CR96","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","volume":"6","author":"MWM K\u00fchn","year":"2016","unstructured":"K\u00fchn MWM, Song E, Feng Z, Sinha A, Chen C-W, Deshpande AJ, et al. Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia. Cancer Discov. 2016;6:1166\u201381.","journal-title":"Cancer Discov"},{"key":"3098_CR97","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2019000802","volume":"134","author":"Y-M Sun","year":"2019","unstructured":"Sun Y-M, Wang W-T, Zeng Z-C, Chen T-Q, Han C, Pan Q, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134:1533\u201346.","journal-title":"Blood"},{"key":"3098_CR98","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s43018-021-00220-w","volume":"2","author":"C Prieto","year":"2021","unstructured":"Prieto C, Nguyen DTT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741\u201357.","journal-title":"Nat Cancer"},{"key":"3098_CR99","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3755","volume":"356","author":"T Han","year":"2017","unstructured":"Han T, Goralski M, Gaskill N, Capota E, Kim J, Ting TC, et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science. 2017;356:eaal3755.","journal-title":"Science"},{"key":"3098_CR100","first-page":"4032","volume":"184","author":"SX Lu","year":"2021","unstructured":"Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M et al. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 2021;184:4032\u201347.","journal-title":"immunity. Cell"},{"key":"3098_CR101","doi-asserted-by":"publisher","first-page":"8269","DOI":"10.1039\/D3SC00985H","volume":"14","author":"S Schmeing","year":"2023","unstructured":"Schmeing S, Amrahova G, Bigler K, Chang J-Y, Openy J, Pal S et al. Rationally designed stapled peptides allosterically inhibit PTBP1\u2013RNA-binding. Chem Sci. 2023;14:8269\u201378.","journal-title":"Chem Sci"},{"key":"3098_CR102","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"3098_CR103","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.molmed.2021.04.005","volume":"27","author":"E El Marabti","year":"2021","unstructured":"El Marabti E, Abdel-Wahab O, et al. Therapeutic modulation of RNA splicing in malignant and non-malignant disease. Trends Mol Med. 2021;27:643\u201359.","journal-title":"Trends Mol Med"},{"key":"3098_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79\u201396.e11.","journal-title":"Cancer Cell"},{"key":"3098_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1563-5","volume":"19","author":"VAC Schoonenberg","year":"2018","unstructured":"Schoonenberg VAC, Cole MA, Yao Q, Macias-Trevi\u00f1o C, Sher F, Schupp PG, et al. CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis. Genome Biol. 2018;19:169.","journal-title":"Genome Biol"},{"key":"3098_CR106","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cells Syst. 2015;1:417\u201325.","journal-title":"Cells Syst"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03098-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:02:45Z","timestamp":1787598165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":106,"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03098-8","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"OA-W is a founder and scientific advisor of Codify Therapeutics, holds equity in this company, and receives research funding from this company. OA-W has served as a consultant for Amphista Therapeutics, Volastra Therapeutics, MagnetBio, and Astra Zeneca, and is on the Scientific Advisory Board of Envisagenics Inc., Harmonic Discovery Inc., and Pfizer Boulder; OA-W has received prior research funding from Nurix Therapeutics and Minovia Therapeutics unrelated to the current manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}